DOCSLIB.ORG

Finding and Preventing Prescription Drug Fraud 18 Benefits Magazine June 2017 by | Susan Hayes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Finding and Preventing Prescription Drug Fraud 18 Benefits Magazine June 2017 by | Susan Hayes Prescription drug fraud can be a costly problem for health plans. The author describes common abuses and recommends steps plan sponsors can take to identify fraud and stop it from happening. Finding and Preventing Prescription Drug Fraud 18 benefits magazine june 2017 by | Susan Hayes MAGAZINE pdf/517 june 2017 benefits magazine 19 prescription drug fraud t seems that a day does not go by cal personnel (physicians, pharmacists, Why Prescription Drug without prescription drug fraud nurses or other medical personnel) Fraud Happens making the headlines. Consider steal drugs for their own use or to sell The regulation or lack of regulation Ithese stories: illegally, is on the rise. The Internation- of pharmacy technicians can be a factor • The city of Kermit, West Virginia al Health Facility Diversion Associa- in prescription drug fraud. For example, is seeking to recoup the costs of tion estimates that 37,000 health care most states require a pharmacy to be dealing with opioid abuse and is professionals are impaired in the Unit- owned and operated by a pharmacist, suing out-of-state drug distribu- ed States on a daily basis from drugs but Florida (one of the most notorious tors.1 stolen from their place of employment.4 states for prescription drug fraud) al- • A former university trustee pleads Prescription drug fraud comes under lows pharmacy technicians to own a guilty to tax evasion charges for the purview of state and federal laws, as pharmacy if they pay $105 and complete prescribing painkillers without a well as Employee Retirement Income a two-week course. Adding to the ripe legitimate medical purpose.2 Security Act (ERISA) regulations. Phar- conditions for fraud is that south Florida • An Amherst, New York doctor is macies and PBMs also are contractually has the highest density of Medicare and sentenced for fraud for writing obligated to not commit fraud. Violators Medicaid recipients in the U.S. more than 200 illegal painkiller of these laws face potential significant Several states, including New York, prescriptions and will spend two jail time (e.g., up to 20 years for medi- Pennsylvania, Wisconsin, Delaware, years in prison.3 cal identity fraud) and may be required Colorado and Hawaii, do not regulate As these examples illustrate, fraud is to make restitution. Perpetrators who pharmacy technicians. In these states, committed at many levels and often by work in the health care industry, such a convicted felon (with a conviction of those we expect to be ethical, making as pharmacists and physicians, also may possession or distribution of controlled it all the more difficult to detect. While temporarily or permanently lose their substances, for example) can work be- many plan sponsors rely on pharmacy license to practice. hind the counter with unfettered access benefit managers (PBMs) to help them Federal laws that encompass pre- to medications. These vital assistants prevent prescription drug fraud, there scription drug fraud include the False perform many routine functions within are actions that plan sponsors, as fidu- Claims Act, wire and mail fraud stat- the pharmacy but also are given a wide ciaries, should take to ensure that their utes, the Health Care Fraud Statute range of discretion. They have the poten- plans and participants don’t fall victim. and theft or embezzlement of health tial to greatly harm patients, since tech- care statutes. The False Claims Act, nicians mix compounds and place the Defining Prescription for example, provides a civil penalty of appropriate drugs in the vial for patients. Drug Fraud between $5,000 and $10,000 for each Many prescription drug fraud The National Health Care Anti- count (i.e., each claim processed) plus schemes involve medical identity theft, Fraud Association in 2009 estimated three times the amount of damages to which can be costly. According to think that annual health care fraud costs as government programs because of the tank Ponemon Institute, a medical much as $234 billion. Prescription drug action. The Civil Monetary Penalties identity theft incident costs patients an fraud can be defined as any unlawful Law provides penalties of $10,000 per average of $22,000 and affects 1.85 mil- act that involves a prescription drug item or service—so for every fraudu- lion Americans.5 and is performed for financial gain. A lent claim processed, the perpetrator wide range of activities qualify under could receive a penalty far in excess of How Fraud Happens this broad definition: drug diversion the actual claim amount or a simple Phantom Prescriptions within a hospital, pharmacists submit- one-for-one damage restitution order. ting fake prescriptions or physicians In addition to laws, each state has In a 2014 case, a California medical writing prescriptions for patients not licensing regulations governing health clinic wrote thousands of fraudulent under their care. care professionals that include provi- prescriptions for antipsychotic medica- Drug diversion, which is when medi- sions against fraud. tions for fictional patients, according 20 benefits magazine june 2017 prescription drug fraud to a statement from the U.S. Attorney’s Office (these fake the PBM has for auditing and prosecuting fraud. Most PBMs prescriptions are commonly referred to as phantom prescrip- have some type of fraud program, but they may not be strong tions). The company then bought back the drugs for a nomi- enough or might fail to find the fraud until after the claims nal fee and diverted them to the black market to sell to other have been paid. pharmacies.6 Some PBM fraud programs may send auditors to a small number of pharmacies to determine if the pharmacy has Institutional Fraud the proper paperwork (e.g., prescription order and signa- Another example of prescription drug fraud involves ture log). If the pharmacy does not have the proper records, institutional fraud (fraud perpetrated by the industry itself: even if the prescription was ordered by a prescriber and the drug companies, mail-order facilities, pharmacy chains and patient requested/received the prescription, the claim is re- PBMs). In one recent case, a drug manufacturer was accused versed, and the plan sponsor may or may not be credited for of hiding its relationship with a network of mail-order phar- the claim.11 macies that solicited physicians and overrode plan design. These procedures, however, are recordkeeping investiga- The mail-order chain helped the pharmaceutical company tions rather than true fraud investigations. Many of the audi- artificially increase its revenue by bending account rules in a tors may have little or no law enforcement/private investi- channel stuffing scheme7 and used coupons to increase sales gation experience and may not properly prepare a case for and to forgive copays.8 prosecution. They also may lack the legal authority to inves- A lawsuit against the manufacturer claimed it was: tigate a pharmacy, since many states require any person who • Actively changing codes on prescriptions to ensure investigates claims and who does not work for an insurance that the prescriptions would be filled with its own drug company, or investigates beyond the claim (meaning investi- rather than a generic equivalent gating ownership or finances of a pharmacy), to be a licensed • Using false pharmacy identification information to bill private investigator.12 payers/PBMs for prescriptions in order to fraudulently bypass payers’ denials of claims for reimbursement Obtain and Review Claims Data • Submitting prescription renewals for reimbursement A significant spike in claims—either from a particular and falsely representing to payers/PBMs that patients pharmacy or provider or a specific therapeutic class (such as had requested renewals of their prescriptions when no compound drugs) can be a warning sign for fraudulent claims. such request had been made Compound drugs are medications that are mixed together • Waiving patient copays through manufacturer cou- and that are not commercially available. Compounding a drug pons or otherwise to remove patients’ incentive to seek is perfectly legal (a) if it is medication that is not commer- out cheaper drugs cially available in the formulation needed by the patient and • Using affiliate pharmacies within its “enterprise” to en- able the mail-order pharmacies to indirectly operate in states where it had been denied a license.9 learn more What Plan Sponsors Should Do Education Visit www.ifebp.org/benefitbits to watch a video of Susan There are efforts within the health care industry to combat Hayes discussing pharmacy fraud. fraud. For example, more than 40 health insurance agencies Fraud Prevention Institute for Employee Benefit Plans have formed the Medical Identity Fraud Alliance to fight med- July 17-18, Chicago, Illinois ical identity theft.10 Plan sponsors, however, should undertake Visit www.ifebp.org/fraudprevention for more information. their own efforts to detect and prevent prescription drug fraud. From the Bookstore Pharmacy Benefits: Plan Design and Management Discuss Fraud With the PBM F. Randy Vogenberg. International Foundation. 2011. Plan sponsors should first talk with their PBMs about Visit www.ifebp.org.books.asp?6962 for more information. fraudulent claims and find out what policies and procedures june 2017 benefits magazine 21 prescription drug fraud geographic area. It is rare that a mem- takeaways ber in Illinois, for example, will travel to • Health care fraud, including prescription drug fraud, is estimated to cost as much as New York to simply obtain a prescrip- $234 billion annually in the United States. tion at a New York pharmacy, especially • Phantom prescriptions—prescriptions for fictional patients—are a common prescription if the physician is also in Illinois. drug fraud scheme. Educate Members About Fraud • Plan sponsors should talk with their pharmacy benefit manager (PBM) to find out what policies and procedures the PBM has for auditing and prosecuting fraud. It’s much less likely for a plan to fall • Warning signs for fraud include a significant spike in claims from a particular pharmacy victim to fraud if plan members are or for a specific therapeutic class of drugs.
Load more

Recommended publications
  • Pharmacy/Prescription Drug Fraud Tips for Protecting Yourself and Medicare
    Pharmacy/Prescription Drug Fraud Tips for Protecting Yourself and Medicare Pharmacy and prescription drug fraud is a consistent trend in Medicare. Due to the lucrative nature of prescription drug diversion and pharmacy scams, criminals continue to exploit Medicare Part D. What is Medicare Pharmacy/Prescription Drug Fraud? Although there are many types of prescription drug schemes, pharmacy fraud primarily occurs when Medicare is billed for a medication that was not received or a beneficiary is intentionally given a different prescription drug than prescribed. What are Examples of Pharmacy/Prescription Drug Fraud? • Billing Medicare for prescription drugs (including refills) that were never picked up, delivered, or even prescribed. • Billing Medicare for prescription drugs (occasionally controlled substances such as opioids) that were prescribed by a health care provider you have never seen. • Billing Medicare for medication amounts beyond the quantity you were prescribed. • Billing Medicare for a different prescription drug (often more expensive) than the one you were originally prescribed or issuing you a drug that is not approved by the U.S. Food and Drug Administration (FDA). • A pharmacy that intentionally provides less medication than prescribed. • A pharmacy that issues expired drugs. • A pharmacy that provides and bills for an expensive compounded medication, including topical pain creams, when a traditional or less expensive prescription was ordered by your provider. • A company offering you “free” or “discount” prescription drugs without a treating physician’s order and then billing Medicare. • A pharmacy offering gift cards or other compensation so you switch your prescriptions over to a specific pharmacy. • A pharmacy automatically refilling a prescription you no longer need.
    [Show full text]
  • Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2019
    The Department of Health and Human Services And The Department of Justice Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2019 June 2020 TABLE OF CONTENTS I. Executive Summary 1 II. Statutory Background 3 III. Program Results and Accomplishments 5 Monetary Results 5 Expenditures 7 Overall Recoveries 8 Health Care Fraud Prevention and Enforcement Action Team 8 Health Care Fraud Prevention Partnership 10 Strike Forces 10 Opioid Fraud and Abuse Detection Unit 13 Highlights of Successful Criminal and Civil Investigations 14 IV. Department of Health and Human Services 39 Office of Inspector General 39 Centers for Medicare & Medicaid Services 61 Administration on Community Living 85 Office of the General Counsel 88 Food and Drug Administration Pharmaceutical Fraud Program 91 V. Department of Justice 95 United States Attorneys 95 Civil Division 96 Criminal Division 102 Civil Rights Division 107 Department of Justice Office of Inspector General 110 VI. Appendix 112 Federal Bureau of Investigation 112 Return on Investment Calculation 116 Total HCFAC Resources 117 VII. Glossary of Terms 118 GENERAL NOTE All years are fiscal years unless otherwise stated in the text. EXECUTIVE SUMMARY The Health Insurance Portability and Accountability Act of 1996 (HIPAA) established a national Health Care Fraud and Abuse Control Program (HCFAC or the Program) under the joint direction of the Attorney General and the Secretary of the Department of Health and Human Services (HHS),1 acting through the Inspector General, designed to coordinate federal, state and local law enforcement activities with respect to health care fraud and abuse. In its twenty-third year of operation, the Program’s continued success confirms the soundness of a collaborative approach to identify and prosecute the most egregious instances of health care fraud, to prevent future fraud and abuse, and to protect program beneficiaries.
    [Show full text]
  • Mail Fraud: Opening Letters
    South Carolina Law Review Volume 43 Issue 2 Article 3 Winter 1992 Mail Fraud: Opening Letters Ellen S. Podgor Georgia State University College of Law Follow this and additional works at: https://scholarcommons.sc.edu/sclr Part of the Law Commons Recommended Citation Podgor, Ellen S. (1992) "Mail Fraud: Opening Letters," South Carolina Law Review: Vol. 43 : Iss. 2 , Article 3. Available at: https://scholarcommons.sc.edu/sclr/vol43/iss2/3 This Article is brought to you by the Law Reviews and Journals at Scholar Commons. It has been accepted for inclusion in South Carolina Law Review by an authorized editor of Scholar Commons. For more information, please contact [email protected]. Podgor: Mail Fraud: Opening Letters SOUTH CAROLINA LAW REVIEW VOLUME 43 WINTER 1992 NUMBER 2 MAIL FRAUD: OPENING LETTERS ELLEN S. PODGOR* I. INTRODUCTION ....................................... 224 II. ELEMENTS ........................................... 225 A. First Element-Scheme to Defraud ............... 226 B. Second Element-Mailing in Furtherance of Schem e ........................................ 229 C. Mail Fraud As It Relates to Wire Fraud and RICO 231 III. SCHEME TO DEFRAUD ................................. 232 A. Intangible Rights Doctrine ....................... 232 B. 1346 Ramifications .............................. 236 IV. IN FURTHERANCE ..................................... 239 A . Conduct ........................................ 240 B. Lim itations ..................................... 242 1. Conflicts with Scheme to Defraud............. 243 2. Imperative Duty Imposed by State ........... 245 3. Mailing Prior to Commencement of Scheme ... 247 * Associate Professor of Law, Georgia State University College of Law. B.S. 1973, Syracuse University; J.D. 1976, Indiana University School of Law at Indianapolis; M.B.A. 1987, University of Chicago; L.L.M. 1989, Temple University School of Law. The author wishes to thank Professors Alfredo Garcia, Eli Lederman, and Laura Webster for their helpful comments throughout the drafting of this article.
    [Show full text]
  • Prescription Drug Fraud and Misuse, 2Nd Edition
    Problem-Specific Guides Series Problem-Oriented Guides for Police No. 24 Prescription Drug Fraud and Misuse 2nd Edition Julie Wartell and Nancy G. La Vigne Problem-Oriented Guides for Police Series Problem-Specific Guide No. 24 Prescription Drug Fraud and Misuse 2nd Edition Julie Wartell Nancy G. La Vigne This project was supported by cooperative agreement #2010-CK-WX-K005 awarded by the Office of Community Oriented Policing Services, U.S. Department of Justice. The opinions contained herein are those of the author(s) and do not necessarily represent the official position or policies of the U.S. Department of Justice. References to specific agencies, companies, products, or services should not be considered an endorsement of the product by the author(s) or the U.S. Department of Justice. Rather, the references are illustrations to supplement discussion of the issues. The Internet references cited in this publication were valid as of the date of this publication. Given that URLs and websites are in constant flux, neither the author(s) nor the COPS Office can vouch for their current validity. © 2013 Center for Problem-Oriented Policing, Inc. The U.S. Department of Justice reserves a royalty-free, nonexclusive, and irrevocable license to reproduce, publish, or otherwise use, and authorize others to use, this publication for Federal Government purposes. This publication may be freely distributed and used for noncommercial and educational purposes. www.cops.usdoj.gov ISBN: 978-1-932582-37-6 April 2013 Originally published May 2004 Updated
    [Show full text]
  • January - December 1992
    January - December 1992 1869 Partnership A&J Cleaning Service A.M. Kirsch Construction Inc. New Business Names, BJ New Business Names, BJ New Business Names, BJ 7/27/92 p21 1/20/92 p21 10/12/92 p20 85 West Street Associates A&M Construction A.P.Z. Painting New Business Names, BJ New Business Names, BJ 6/8/92 New Business Names, BJ 11/23/92 p20 p25 3/30/92 p20 911. SEE EMERGENCY A&M Vending A.R.M.S. of Connecticut COMMUNICATION SYSTEMS New Business Names, BJ New Business Names, BJ 7SS Mailorder 8/17/92 p22 11/9/92 p20 New Business Names, BJ A&S Investment A.R.S. 9/21/92 p20 New Business Names, BJ New Business Names, BJ 313-18 Federal Road Corp. 10/5/92 p20 2/17/92 p33 Bankruptcies, BJ 10/5/92 p19 A&S Laundrette A.S. Construction Service 34 Wall Street Building Account New Business Names, BJ New Business Names, BJ New Business Names, BJ 6/22/92 p13 7/13/92 p20 2/17/92 p33 A&V Variety A.V.R. Electronics 3-Star Screen Printing & Athletic New Business Names, BJ New Business Names, BJ Accessories 2/10/92 p20 9/21/92 p20 New Business Names, BJ A-1 Auto Painting & Bodywork AA Malloy Insurance 4/13/92 p20 New Business Names, BJ New Business Names, BJ 3P Industries 11/9/92 p21 7/27/92 p21 New Business Names, BJ A-1 Medical & Executive AAA Services 4/13/92 p20 Answering Service New Business Names, BJ 20 Orchard Street Corp.
    [Show full text]
  • Office of Statewide Prosecution 2003 Annual Report
    OFFICE OF STATEWIDE PROSECUTION 2003 ANNUAL REPORT Submitted by Peter Williams, Statewide Prosecutor March 1, 2004 Charlie Crist Peter Williams Attorney General Statewide Prosecutor OFFICE OF STATEWIDE PROSECUTION 2003 ANNUAL REPORT This Annual Report for the Office of Statewide Prosecution is being filed pursuant to Section 16.56 (2), Florida Statutes, and contains a summary of the activities of the Office for 2003 as well as the goals and objectives for 2004. EXECUTIVE SUMMARY OF THE OFFICE’S ACTIVITIES In Fiscal Year 2002-2003, the Office of Statewide Prosecution handled a total volume of 1,000 complex criminal investigations and prosecutions, including 628 filed cases and worked in conjunction with 101 law enforcement agencies and numerous State and Federal Task Forces. This volume was achieved in spite of a ten percent budget cut for Fiscal Year 2003-2004, and represents a six percent increase in the number of filed cases over the prior fiscal year. The overall conviction rate was 91%. The financial benefit to the citizens of the State of Florida in the form of assessed fines, penalties, and ordered restitution amounted to over $27 million, which greatly exceeded the total operating budget of the Office of Statewide Prosecution. MISSION OF THE OFFICE The Office of Statewide Prosecution was created by constitutional amendment passed by Florida voters in 1986. Article IV, Section 4 of the Florida Constitution, together with Section 16.56, Florida Statutes, sets forth the jurisdiction and authority of the Office. The Office was created because organized criminal activity does not respect the geographic boundaries imposed by judicial circuit lines.
    [Show full text]
  • Page 1 of 4 Drug-Abuse Problems Evade Part D Anti-Fraud Efforts
    Drug-abuse problems evade Part D anti-fraud efforts | Modern Healthcare Page 1 of 4 ACA ACOs Finance Government Healthcare IT Payers Physicians Safety/Quality Supply Chain Log in | Free Newsletters | Subscribe | Get Password | Help Join, Follow & Connect News Topics Research Opinion Blog Recognition Videos & Webinars Events Marketplace Jobs Healthcare Business News This Week's Issue Painful side effects Outlook 2014: Drug-abuse problems evade paltry anti-fraud efforts in Medicare Part D Healthcare industry can expect promises, challenges and growth By Joe Carlson Posted: April 12, 2013 - 12:01 am ET Startup insurer Oscar Tags: Feature, Fraud, Legal, Medicare, Pharmaceuticals, Recovery Audit Inc. hopes high-tech, Contractor (RAC) service will trump incumbents Table of Contents The abuse of prescription painkillers causes more fatalities than heroin and Digital Edition Stanford team answers cocaine use combined—more than 40 deaths every day. Subscribe call to aid typhoon victims Yet programs that could stop the types of Medicare fraud that commonly lead to powerful drugs being diverted into the black market aren't working as well as they should. By the numbers: Uninsured young Such breakdowns are often framed largely in terms of financial losses, such as the widely touted statistic that prescription Americans by state drug fraud costs public and private insurers about $73 billion a year. But unlike other areas of Medicare fraud, prescription drug abuse levels a heavy human toll seen in the rising rates of deaths and addictions, the births of drug-addicted babies and destruction wrought on rural towns hard-hit by the painkiller epidemic. A report from the Government Accountability Office found in Advertisement | View Media Kit 2011 that 170,000 Medicare beneficiaries got prescription painkillers from five or more doctors, which is a warning sign Most Requested Articles for fraudulent “doctor-shopping” by drug-seeking individuals.
    [Show full text]
  • Curbing Prescription Drug Abuse in Medicare Hearing
    S. Hrg. 113–244 CURBING PRESCRIPTION DRUG ABUSE IN MEDICARE HEARING BEFORE THE COMMITTEE ON HOMELAND SECURITY AND GOVERNMENTAL AFFAIRS UNITED STATES SENATE ONE HUNDRED THIRTEENTH CONGRESS FIRST SESSION JUNE 24, 2013 Available via the World Wide Web: http://www.fdsys.gov/ Printed for the use of the Committee on Homeland Security and Governmental Affairs ( U.S. GOVERNMENT PRINTING OFFICE 82–571 PDF WASHINGTON : 2014 For sale by the Superintendent of Documents, U.S. Government Printing Office Internet: bookstore.gpo.gov Phone: toll free (866) 512–1800; DC area (202) 512–1800 Fax: (202) 512–2104 Mail: Stop IDCC, Washington, DC 20402–0001 COMMITTEE ON HOMELAND SECURITY AND GOVERNMENTAL AFFAIRS THOMAS R. CARPER, Delaware Chairman CARL LEVIN, Michigan TOM COBURN, Oklahoma MARK L. PRYOR, Arkansas JOHN MCCAIN, Arizona MARY L. LANDRIEU, Louisiana RON JOHNSON, Wisconsin CLAIRE MCCASKILL, Missouri ROB PORTMAN, Ohio JON TESTER, Montana RAND PAUL, Kentucky MARK BEGICH, Alaska MICHAEL B. ENZI, Wyoming TAMMY BALDWIN, Wisconsin KELLY AYOTTE, New Hampshire HEIDI HEITKAMP, North Dakota JEFF CHIESA, New Jersey RICHARD J. KESSLER, Staff Director JOHN P. KILVINGTON, Deputy Staff Director PETER P. TYLER, Senior Professional Staff Member WALTER S. OCHINKO, GAO Detailee KEITH B. ASHDOWN, Minority Staff Director CHRISTOPHER J. BARKLEY, Minority Deputy Staff Director JOSH TRENT, Health Policy Advisor, Office of Senator Coburn TRINA D. SHIFFMAN, Chief Clerk LAURA W. KILBRIDE, Hearing Clerk (II) C O N T E N T S Opening statements: Page Senator Carper ................................................................................................
    [Show full text]
  • Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2015
    The Department of Health and Human Services And The Department of Justice Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2015 FEBRUARY 2016 TABLE OF CONTENTS I. Executive Summary 1 II. Statutory Background 3 III. Program Results and Accomplishments 5 Monetary Results 5 Expenditures 7 Overall Recoveries 8 Health Care Fraud Prevention and Enforcement Action Team 8 Health Care Fraud Prevention Partnership 9 Medicare Fraud Strike Force 10 Highlights of Successful Criminal and Civil Investigations 12 IV. Department of Health and Human Services 36 Office of Inspector General 36 Centers for Medicare & Medicaid Services 45 Administration on Community Living 56 Office of the General Counsel 58 Food and Drug Administration Pharmaceutical Fraud Program 62 V. Department of Justice 64 United States Attorneys 64 Civil Division 66 Criminal Division 69 Civil Rights Division 72 VI. Appendix 77 Federal Bureau of Investigation 77 Return on Investment Calculation 80 Total HCFAC Resources 81 VII. Glossary of Terms 82 GENERAL NOTE All years are fiscal years unless otherwise noted in the text. EXECUTIVE SUMMARY The Health Insurance Portability and Accountability Act of 1996 (HIPAA) established a national Health Care Fraud and Abuse Control Program (HCFAC or the Program) under the joint direction of the Attorney General and the Secretary of the Department of Health and Human Services (HHS)1, acting through the Inspector General, designed to coordinate federal, state and local law enforcement activities with respect to health care fraud and abuse. In its nineteenth year of operation, the Program’s continued success confirms the soundness of a collaborative approach to identify and prosecute the most egregious instances of health care fraud, to prevent future fraud and abuse, and to protect program beneficiaries.
    [Show full text]
  • Health Frauds and Quackery Hearings
    HEALTH FRAUDS AND QUACKERY HEARINGS BEFORE THE SUBCOMMITTEE ON FRAUDS AND MISREPRE- SENTATIONS AFFECTING THE ELDERLY OF THE SPECIAL COMMITTEE ON AGING UNITED STATES SENATE EIGHTY-EIGHTH CONGRESS SECOND SESSION Part 1.-San Francisco, Calif. JANUARY 13, 1964 Printed for the use of the Special Committee on Aging U.S. GOVERNMENT PRINTING OFFICE 31-135 WASHINGTON: 1964 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington., D.C. 20402 -Price 45 cents SPECIAL COMMITTEE ON AGING GEORGE A. SMATHERS, Florida, Chairman PAT McNAMARA, Michigan EVERETT McKINLEY DIRKSEN, Illinois CLAIR ENGLE, California BARRY GOLDWATER, Arizona HARRISON A. WILLIAMS, JR., New Jersey FRANK CARLSON, Kansas MAURINE B. NEUBERGER, Oregon WINSTON L. PROUTY, Vermont WAYNE MORSE, Oregon KENNETH B. KEATING, New York ALAN BIBLE, Nevada HIRAM L. FONG, Hawaii FRANK CHURCH, Idaho E. L. MECHEM, New Mexico JENNINGS RANDOLPH, West Virginia EDMUND S. MUSKIE, Maine EDWARD V. LONG, Missouri FRANK E. MOSS, Utah EDWARD M. KENNEDY, Massachusetts RALPH W. YARBOROUGH, Texas J. WiLmamaa NORMAN, Jr., Staff Director JoHIN Guy MILLER, Minority Staff Director SUBCOMMITTEE ON FRAUDS AND MISREPRESENTATIONS AFFECTING TEE ELDERLY HARRISON A. WILLIAMS, JR., New Jersey, Chairman MAURINE B. NEUBERGER, Oregon KENNETH B. KEATING, New York WAYNE MORSE, Oregon WINSTON L. PROUTY, Vermont FRANK CHURCH, Idaho HIRAM L. FONG, Hawaii EDMUND S. MUSKIE, Maine E. L. MECHEM, New Mexico EDWARD V. LONG, Missouri EDWARD M. KENNEDY, Massachusetts RALPH W. YARBOROUGH, Texas WILLIAM E. ORIOL, Professional Staff Member NOTE.-Four hearings on health frauds and quackery were held and they are identified as follows: Part 1-San Francisco, Calif., Jan.
    [Show full text]
  • Smp Foundations Training Manual
    SMP Foundations Training Manual SMP Resource Center Table of Contents Acknowledgements ................................................................... i About the SMP Resource Center .............................................. i Training Overview .................................................................... ii Updates Since August 2014 ....................................................iii Chapter 1: SMP Program Objectives ................................................................................. 3 The SMP Mission ...................................................................... 3 SMP is a National Program....................................................... 6 The Importance of Volunteers................................................... 9 How Does the Public Find Their SMP? ................................... 10 Chapter 2: Medicare Basics Objectives ............................................................................... 13 Medicare Overview ................................................................. 14 Original Medicare .................................................................... 17 Medicare Part C: Medicare Advantage ................................... 24 Medicare Part D: Prescription Drugs ...................................... 26 Medicare Enrollment Periods .................................................. 27 Medicare Statements and Claims Tracking ............................ 33 Assistance for People with Limited Income and Resources ... 49 Medicare Rights and Protections ...........................................
    [Show full text]
  • Health Care Fraud and Abuse Control Program, Annual Report for Fiscal
    The Department of Health and Human Services And The Department of Justice Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2016 January 2017 TABLE OF CONTENTS I. Executive Summary 1 II. Statutory Background 3 III. Program Results and Accomplishments 5 Monetary Results 5 Expenditures 7 Overall Recoveries 8 Health Care Fraud Prevention and Enforcement Action Team 8 Health Care Fraud Prevention Partnership 9 Medicare Fraud Strike Force 10 Highlights of Successful Criminal and Civil Investigations 12 IV. Department of Health and Human Services 34 Office of Inspector General 34 Centers for Medicare & Medicaid Services 43 Administration on Community Living 60 Office of the General Counsel 62 Food and Drug Administration Pharmaceutical Fraud Program 66 V. Department of Justice 69 United States Attorneys 69 Civil Division 70 Criminal Division 74 Civil Rights Division 77 VI. Appendix 82 Federal Bureau of Investigation 82 Return on Investment Calculation 85 Total HCFAC Resources 86 VII. Glossary of Terms 87 GENERAL NOTE All years are fiscal years unless otherwise stated in the text. EXECUTIVE SUMMARY The Health Insurance Portability and Accountability Act of 1996 (HIPAA) established a national Health Care Fraud and Abuse Control Program (HCFAC or the Program) under the joint direction of the Attorney General and the Secretary of the Department of Health and Human Services (HHS)1, acting through the Inspector General, designed to coordinate federal, state and local law enforcement activities with respect to health care fraud and abuse. In its twentieth year of operation, the Program’s continued success confirms the soundness of a collaborative approach to identify and prosecute the most egregious instances of health care fraud, to prevent future fraud and abuse, and to protect program beneficiaries.
    [Show full text]